Here is a link to the press announcement from manufacturer, GlaxoSmithKline of the UK. US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults | GSK “About Arexvy (respiratory syncytial virus vaccine, adjuvanted)
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…